P2.01-01 Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 ≥50%
JOURNAL OF THORACIC ONCOLOGY（2019）
关键词
non-small-cell lung cancer,anti-PD-1,cemiplimab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要